Corporate Research & Development Center

Research News


Dec. 2019

Nov. 2019

  • Shinshu University and Toshiba Begin Collaborative Research on Application of Biodegradable Liposomes in Cancer Gene Therapy
    -Delivery of Genes via Non-viral Nanocapsules-
    (11 Nov, 2019) TOKYO─Toshiba Corporation (TOKYO: 6502) collaborates with a team at the Department of Pediatrics, Shinshu University Graduate School of Medicine, led by Professor Yozo Nakazawa (hereinafter "Shinshu University"), in a project that has begun collaborative research on an anti-cancer gene delivery technology that will deliver therapeutic genes to cancerous cells in nanosized capsules made with biodegradable lipids (hereinafter "biodegradable liposome". The biodegradable liposomes efficiently deliver the genes to target cells, are well suited to mass production, and are expected to find wide application. This integration of Shinshu University's cancer research and Toshiba's materials research will help to expand gene therapies for cancer(Note 1).

Oct. 2019

Sep. 2019

Aug. 2019

Jun. 2019

May. 2019

Apr. 2019

Mar. 2019

Jan. 2019